2,679 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Purchased by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,679 shares of the company’s stock, valued at approximately $209,000.

Other large investors have also recently made changes to their positions in the company. LGT Financial Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares during the period. Capital Performance Advisors LLP purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $26,000. Ashton Thomas Securities LLC purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $26,000. Darwin Wealth Management LLC purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $31,000. Finally, Continuum Advisory LLC boosted its stake in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after purchasing an additional 168 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 0.5 %

NASDAQ:GEHC opened at $84.76 on Thursday. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The firm has a market cap of $38.76 billion, a P/E ratio of 19.58, a P/E/G ratio of 3.19 and a beta of 1.15. The firm has a 50-day simple moving average of $86.52 and a 200-day simple moving average of $86.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on GEHC. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Finally, Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.